Share:
Peer-Reviewed Publication
Cardiovasc Digit Health J2022;3(5):201-211.October 1, 2022Journal Article

Artificial intelligence augments detection accuracy of cardiac insertable cardiac monitors: Results from a pilot prospective observational study.

Fabio Quartieri1, Manuel Marina-Breysse2,3,4, Annalisa Pollastrelli5, Isabella Paini1, Carlos Lizcano2, José María Lillo-Castellano2,3,6, Andrea Grammatico5
1Department of Cardiology, Azienda Ospedaliera S. Maria Nuova, Reggio Emilia, Italy.
2IDOVEN Research, AI Team, Madrid, Spain.
3Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
4Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
5EMEA CRM Medical Affairs, Abbott, Rome, Italy.
6Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Madrid, Spain.

Abstract

BACKGROUND: Insertable cardiac monitors (ICMs) are indicated for long-term monitoring of patients with unexplained syncope or who are at risk for cardiac arrhythmias. The volume of ICM-transmitted information may result in long data review times to identify true and clinically relevant arrhythmias. OBJECTIVE: The purpose of this study was to evaluate whether artificial intelligence (AI) may impro…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.